Biggar Stephen R 4
4 · SYNAGEVA BIOPHARMA CORP · Filed Jun 29, 2012
Insider Transaction Report
Form 4
Biggar Stephen R
Director
Transactions
- Award
Stock Option (Right to Buy)
2012-06-27+7,500→ 7,500 totalExercise: $40.74Exp: 2022-06-27→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]1/12 of the shares subject to this option vest and become exercisable on July 27, 2012 and monthly thereafter.